DIRECT MEDICAL COSTS AND RESOURCE USE FOR TREATING CENTRAL AND BRANCH RETINAL VEIN OCCLUSION IN COMMERCIALLY INSURED WORKING-AGE AND MEDICARE POPULATIONS